Quick answers
- Is there a shortage of Dextrose?
- The FDA drug shortage list shows “Current shortage” for a product of this medicine (updated October 19, 2026). Ask your pharmacist about alternatives.
- Has Dextrose been recalled?
- FDA enforcement reports list 1 recall of products of this medicine; the newest started April 2, 2026 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Dextrose?
- 1 company lists prescription products of Dextrose in the FDA NDC Directory, including B. Braun Medical Inc..
What Dextrose is used for
We did not find an “Indications and Usage” section in the FDA labels for this medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Forms and how it is given
| Dosage forms | Solution |
|---|---|
| Route | Intravenous |
| Prescription products | 1 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- B. Braun Medical Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA019626 DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE 2.5% IN PLASTIC CONTAINER, DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 7.7% IN PLASTIC CONTAINER, DEXTROSE 70% IN PLASTIC CONTAINER | B Braun | February 2, 1988 | 21, latest October 20, 2026 2026: Labeling · 2015: Manufacturing (CMC) · 2015: Manufacturing (CMC) |
Shortage status
Current shortage · updated October 19, 2026 · first posted October 11, 2024
| Product | Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50) |
|---|---|
| Availability | Available |
| Company | B. Braun Medical Inc. |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 2, 2026 · Class II · Ongoing · D-0496-2026
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50. — B BRAUN MEDICAL INC
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| FDA labels (SPL) | 0 |
|---|---|
| FDA applications | NDA019626 |
| Active ingredients (FDA) | DEXTROSE |
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →